基因组信息化风险评估在预测痴呆症结果中的作用
Shea J Andrews1,2, Paulina Tolosa-Tort1, Caroline Jonson2,3,4
1Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
大多数记忆诊所患者都有痴呆症风险因素. 每一个额外的风险指标都显著增加了痴呆症发病风险,突出了个性化大脑健康策略的必要性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 老年学是指老年学的学科.
背景情况:
- 将遗传和临床因素纳入痴呆风险报告有助于患者理解.
- 基因组信息报告支持个性化大脑健康策略.
研究的目的:
- 评估遗传和临床风险因素与痴呆症进展之间的关联.
主要方法:
- 使用mCAIDE,家族史,APOE基因型和AD多基因风险评分构建了一个附加风险评分.
- 利用了来自国家阿尔茨海默氏症协调中心 (NACC) 和ADNI.的数据.
主要成果:
- 81%的参与者至少有一个痴呆症高风险指标.
- 每一个额外的风险指标都会增加34%的痴呆发病风险.
结论:
- 大多数记忆诊所患者都表现出痴呆症风险指标.
- 风险指标负担和痴呆风险之间存在剂量反应关系.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Alzheimer's Disease: Treatment
